α1-Antitrypsin deficiency: Best clinical practice

Journal of Clinical Pathology

Volumn 62, Issue 10, 2009, Pages 865-869

  Kalsheker, N A ^a  

^a NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTITRYPSIN; LEUKOCYTE ELASTASE; MUTANT PROTEIN; PROTEINASE INHIBITOR; SERINE PROTEINASE; SERINE PROTEINASE INHIBITOR;

ALLELE; ALPHA 1 ANTITRYPSIN DEFICIENCY; ANTIINFLAMMATORY ACTIVITY; CHILDHOOD DISEASE; CHRONIC DISEASE; CLINICAL PRACTICE; CYTOKINE PRODUCTION; DISEASE PREDISPOSITION; DISEASE SEVERITY; ENZYME INHIBITION; ENZYME REPLACEMENT; EUROPE; GENOTYPE; HUMAN; INHERITANCE; INNATE IMMUNITY; LIVER; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; LUNG EMPHYSEMA; LUNG TRANSPLANTATION; NEWBORN JAUNDICE; PREVALENCE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN POLYMERIZATION; REVIEW; SMOKING; TREATMENT OUTCOME; ADULT; ARTICLE; GENETICS; METHODOLOGY;

ADULT; ALPHA 1-ANTITRYPSIN; ALPHA 1-ANTITRYPSIN DEFICIENCY; ENZYME REPLACEMENT THERAPY; HUMANS; LIVER CIRRHOSIS; PULMONARY EMPHYSEMA;

EID: 70349694399     PISSN: 00219746     EISSN: 14724146     Source Type: Journal    
DOI: 10.1136/jcp.2008.063495     Document Type: Review

References (36)

1. Laurell CB, Erikssons S. The electrophoretic α1-globulin pattern in serum α1 antitrypsin deficiency. Scand J Clin Lab Invest 1963;15:132-140
2. Knight KR, Burdon JG, Cook L, et al. The proteinase-antiproteinase theory of emphysema: a speculative analysis of recent advances into the pathogenesis of emphysema. Respirology 1997;2:91-95 (Pubitemid 27353513)
3. Cambell EJ. Animal models of emphysema: the next generations. J Clin Invest 2000;106:1445-1446
4. 1-antitrypsin deficiency. Lancet 2005;365:2225-2236
5. Silverman EK, Pierce JA, Province MA, et al. Variability of pulmonary function in alpha1-antitrypsin deficiency: clinical correlates. Ann Intern Med 1989;111:982-991
6. Elliott PR, Stein PE, Bilton D, et al. Structural explanation for the dysfunction of S α1- antitrypsin. Nature Struc Biol 1996;3:910-911
7. 1-antitrypsin deficiency panniculitis. Cutis 2003;71:205-209
8. 1-antitrypsin deficiency. Q J Med 1996;89:877.
9. Halkas AC, Gaillard MC, Thomson PD, et al. Variants of alpha 1-proteinase inhibitor in black and white South African patients with focal glomerulosclerosis and minimal change nephrotic syndrome. J Med Genet 1998;35:6-9.
10. Novis BH, Young GO, Bank S, et al. Chronic pancreatitis and alpha1-antitrypsin deficiency. Lancet 1975;2:748-749
11. Demeo DL, Campbell EJ, Barker AF, et al. IL10 polymorphisms are associated with airflow obstruction in severe alpha1-antitrypsin deficiency. Am J Respir Cell Mol Biol 2008;38:114-120
12. Woods AM, Simmonds MJ, Bayley DL, et al. The TNF alpha gene relates to clinical phenotype in alpha1-antitrypsin-deficiency. Respir Res 2008;9:52.
13. Tanash HA, Nilsson PM, Nilsson JA, et al. Clinical course and prognosis of never smokers with severe alpha1-antitrypsin deficiency. Thorax 2008;63:1091-1095
14. Campos MA, Alazemi S, Zhang G, et al. Clinical characteristics of subjects with symptoms of alpha1-antitrypsin deficiency older than 60 years. Chest 2009;135:600-608
15. Chappell S, Hadzic N, Stockley R, et al. A polymorphism of the alpha1-antitrypsin gene represents a risk factor for liver disease. Hepatology 2008;47:127-132 (Pubitemid 351171049)
16. De Serres FJ, Blanco I, Fernandez-Bustillo E. Genetic epidemiology of alpha1- antitrypsin deficiency in North America and Australia. Clin Genet 2003;64:382-397
17. Larsson C. Natural history and life expectancy in severe alpha1-antitrypsin deficiency Pi Z. Acta Med Scand 1978;204:345-351 (Pubitemid 9051719)
18. Tobin MJ, Cook PJL, Hutchinson DCS. Alpha1-antitrypsin deficiency: the clinical and physiological features of pulmonary emphysema subjects homozygous for Pi type Z. Br J Dis Chest 1983;77:12-27.
19. Campos MA, Wanner A, Zhang G, et al. Trends in the diagnostics of symptomatic patients with alpha1-antitrypsin deficiency between 1968 and 2003. Chest 2005;128:1179-1186
20. Bals R, Koczulla R, Kotke V, et al. Identification of individuals with α1-antitrypsin deficiency as a targeted screening program. Respir Med 2007;101:1708-1714 (Pubitemid 46947877)
21. Stoller JK, Smith P, Yang P, et al. Physical and social impact of α1-antitrypsin deficiency: results of a survey. Cleve Clin J Med 1994;61:461-467
22. 1-antitrypsin deficiency. New Engl J Med 1990;302:272-275
23. Francavilla F, Castallanetta SP, Hodzic N, et al. Prognosis of α1-antitrypsin deficiency related liver disease in the era of paediatric liver transplantation. J Hepatol 2000;32:986-992
24. Eriksson S, Haegerstrad I. Cirrhosis and malignant hepatoma in α1-antitrypsin deficiency. Acta Med Scand 1974;193:451-458
25. Gouindarajan S, Aschauvi M, Peters RL. α1-antitrypsin deficiency phenotypes in hepatocellular carcinoma. Hepatology 1981;1:628-631
26. Brantly M. α1-Antitrypsin: Not just an antiprotease. Extending the half life of a natural anti-inflammatory molecule by conjugation with polyethylene glycol. Am J Respir Cell Mol Biol 2002;27:652-654 (Pubitemid 35381172)
27. Pott GB, Chan ED, Dinarello CA, et al. Alpha-1-antitrypsin is an endogenous inhibitor of procytokine production in whole blood. J Leuk Biol 2009;85:886-895
28. Zhang B, Lu Y, Campbell-Thompson M, et al. α1-antitrypsin protects β-cells from apoptosis. Diabetes 2007;56:1316-1323
29. Huang H, Campbell SC, Nelius T, et al. α1-antitrypsin inhibits angiogenesis and tumour growth. Int J Cancer 2004;112:1042-1048 (Pubitemid 39507012)
30. Zorzetto M, Russi E, Senn O, et al. SERPINA1 gene variants in individuals from the general population with reduced α1-antitrypsin concentrations. Clin Chem 2008;5:1331-1338
31. 1- antitrypsin standard to establish ranges for the common normal and deficient α1- antitrypsin phenotypes. Chest 1991;100:703-708
32. Heresi GA, Stoller JK. Augmentation therapy in alpha1-antitrypsin deficiency. Expert Opin Biol Ther 2008;4:515-526
33. Russi EW. Alpha1-antitrypsin: now available but do we need it? Swiss Med Wkly 2008;138:192-196
34. Stoller JK, Aboussouan LS. α1-antitrypsin deficiency. Lancet 2005;365:2225-2236
35. Brand P, Schulte M, Wencker M, et al. Lung deposition of inhaled alpha1-proteinase inhibitor in CF and alpha1-antitrypsin deficiency. Eur Respir J. Published online: 27 February 2009. doi:10.1183/09031936.00118408
36. Mallya M, Phillips RL, Saldanha SA, et al. Small molecules block the polymerisation of Z alpha1-antitrypsin and increase the clearance of intracellular aggregates. J Med Chem 2007;50:5357-5363 (Pubitemid 350057847)